In silico Prediction of Anti-bacterial Potentials of Some Synthesized Sulfonamide Compounds

• Autorzy: , , Uju M. Ikezu
• Języki publikacji: EN

Abstrakty

EN

Overuse and misuse of antibiotics as well as social and economic factors have accelerated the spread of antibiotic-resistant bacteria, making drug treatment ineffective. This study aimed at screening some sulphonamide compounds in other to recommend new anti-bacteria drugs with better efficacy and lower toxicity. The ten (10) sulfonamide compounds were screened for their antibacterial activities against medically important gram (-) and gram (+) bacterial strains, namely, Escherichia coli (E. coli), Pseudomonas aeruginosa (P. aeruginosa), Bacillus cereus (B. cereus) and Staphylococcus aureus (Staph aureus). The antibacterial activities have been determined by in silico molecular docking of the ten (10) sulphonamide compounds on the targeted site of the organism`s protein. Among the tested compounds, it was found that ciprofloxacin was the most potent against E. coli with the highest binding affinity (-13.17 kcal/mol), while compounds; 3-(3H-indol-3-yl)-2-[(phenylsulfonyl)amino] propanoic acid (1906; -12.93 kcak/mol), {[(4-methylphenyl)sulfonyl]amino}-3-methylbutanoic acid (1909; -12.83 kcal/mol) and 3-(4-hydroxyphenyl)-2-[(phenylsulfonyl)amino]propanoic acid (1902; -12.48 kcal/mol) gave better binding scores than ciprofloxacin (-12.25 kcal/mol) with Pseudomonas aeruginosa. On the binding with Bacillus aereus protein, 2-[(phenylsulfonyl)amino]-3-sulfanylpropanoic acid (1904; -15.54 kcal/mol), 3-(4-hydroxyphenyl)-2-[(phenylsulfonyl)amino] propanoic acid (1902; -15.46 kcal/mol) and 3-(4-hydroxyphenyl)-2-{[(4methylphenyl)sulfonyl]anino} propanoic acid (1901; -15.45 kcal/mol), showed better binding affinity than cipro (-15.36 kcal/mol), while ciprofloxacin gave the highest binding affinity (-12.08 kcal/mol) with Staphylococcus aureus protein (3G75) when compared to the analysed sulfonamide compounds. The analysed 10 sulfonamide compounds showed potential drug candidates by obeying all the physicochemical parameters that qualifies a compound to be used as drug and therefore, can be clinically use for the treatment of diseases caused by the named organisms.

Słowa kluczowe

EN

anti-bacteria; ciprofloxacin; drugs; physicochemical; sulphonamide

• Wydawca: Scientific Publishing House „DARWIN”
• Czasopismo: World News of Natural Sciences
• Rocznik: 2024
• Tom: 55
• Strony: 87-101

Twórcy

autor

,

• Department of Chemistry, Imo State University, Owerri, Imo State Nigeria

autor

Uju M. Ikezu

• Department of Chemistry, Imo State University, Owerri, Imo State Nigeria

Bibliografia

• [1] LiverTox. Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. Sulfonamides. PMID: 2017 31643703
• [2] Henry, R.I. The mode of action of sulphonamide. Bacteriological Reviews 1943, 7(4): 175-262
• [3] Ugwu, D. I, Okoro, U.C, and Chukwurah, T.D. Nickel catalyzed synthesis of N-aryl and N-heteroaryl substituted benzene sulphonamides and their biological activities evaluation. Journal of Medicinal Chemistry 2014, 4(3): 357-360
• [4] Konda, S., Raparthi, S., Bhaskar, K., Munaganti, R.K., Guguloth, V., Nagarapu, L., and Akkewar D.M. Synthesis and antimicrobial activity of novel benzoxazine sulfonamide derivatives. Bioorg. Med. Chem. Lett; 2015, 25: 1643–1646
• [5] Owa, T., and Nagasu, T. Novel sulphonamide derivatives for the treatment of cancer. Expert Opin. Ther. Pat; 2000, 10: 1725–1740
• [6] Liu, Zl., Tian, W., Wang, Y. et al. A novel sulfonamide agent, MPSP-001, exhibits potent activity against human cancer cells in vitro through disruption of microtubule. Acta Pharmacol Sin. 2012, 33, 261–270
• [7] Chandna, N., Kumar, S., Kaushik, P., Kaushik, D., Roy, S.K., Gupta, G.K., Jachak, S.M., Kapoor, J.K., and Sharma, P.KSynthesis of novel celecoxib analogues by bioisosteric replacement of sulfonamide as potent anti-inflammatory agents and cyclooxygenase inhibitors. Bioorg. Med. Chem 2013, 21: 4581–4590
• [8] Sameena, B., Kalim, J., Shamim, A., Rathish, I.G., Surender, S., and Alam, M.S. Synthesis and biological evaluation of some new 2-pyrazolines bearing benzene sulfonamide moiety as potential anti-inflammatory and anti-cancer agents. Eur. J. Med. Che 2011, 46: 5763–5768
• [9] Hamaguchi, T., Hirose, T., Asakawa, H., Itoh, Y., Kamado, K., Tokunaga, K., Tomita, K., Masuda, H., Watanabe, N., and Namba, M. Efficacy of glimepiride in type 2 diabetic patients treated with glibenclamide. Diabetes Res Clin Pract. 66 Suppl; 2004, 1: S129-32. doi: 10.1016/j.diabres.2003
• [10] Allen, H.B., and Lee, D.A. A general practice assessment of mefruside ('Baycaron') in the treatment of oedema and hypertension. Curr. Med. Res. Opin 1973, 1: 547–553
• [11] Chandna N., Kumar S., Kaushik P., Kaushik D., Roy S.K., Gupta G.K., Jachak S.M., Kapoor J.K., Sharma P.K. Synthesis of novel celecoxib analogues by bioisosteric replacement of sulfonamide as potent anti-inflammatory agents and cyclooxygenase inhibitors. Bioorg. Med. Che 2013, 21: 4581–4590
• [12] Sameena, B., Kalim, J., Shamim, A., Rathish, I.G., Surender, S., and Alam M.S. Synthesis and biological evaluation of some new 2-pyrazolines bearing benzene sulfonamide moiety as potential anti-inflammatory and anti-cancer agents. Eur. J. Med. Che; 2011, 46:5 763–5768
• [13] Thakur, A., Manohar, S., Velez Gerena, C.E., Zayas, B., Kumar, V., Malhotra, S.V., and Rawat D.S. Novel 3,5-bis(arylidiene)-4-piperidone based monocarbonyl analogs of curcumin: anticancer activity evaluation and mode of action study. Med. Chem. Commun; 2014, 5(5): 576–586
• [14] Ghorab, M.M., Alsaid, M.S., El-Gaby, M.S., Safwat, N.A., Elaasser, M.M., and Soliman, A.M. Biological evaluation of some new N-(2,6-dimethoxypyrimidinyl)thioureido benzenesulfonamide derivatives as potential antimicrobial and anticancer agents. Eur. J. Med. Chem; 2016, 124: 299–310
• [15] Shen, C.H., Wang, Y.F., Kovalevsky, A.Y., Harrison, R.W., and Weber, I.T. Amprenavir complexes with HIV-1 protease and its drug-resistant mutants altering hydrophobic clusters. FEBS J 2010, 277: 3699–3714
• [16] Aadil, A., Shahzad, M., Muhammad, N.T., Saima S., Muhammad, S., Usman, A.R., Khadija N., and Hummera, R. Synthesis, antioxidant, enzyme inhibition and DNA binding studies of novel N-benzylated derivatives of sulphonamide. J. Mol. Struc; 2016, 1117: 269–275
• [17] Boechat, N., Pinheiro, L.C., Santos-Filho, O.A., and Silva, I.C. Design and synthesis of new N-(5-Trifluoromethyl)-1H-1,2,4-triazol-3-yl benzenesulfonamides as possible antimalarial prototypes. Molecules; 2011. 16:8083–8097.
• [18] Quintana C., Silva G., Klahn A.H., Artigas V., Fuentealba M., Biot C., Halloum I., Kremer L., Novoa N., and Arancibia R. New cyrhetrenyl and ferrocenyl sulfonamides: synthesis, characterization, X-ray crystallography, theoretical study and anti-Mycobacterium tuberculosis activity. Polyhedron 2017, 134: 166–172
• [19] Gawin, R., De Clercq, E., Naesens, L., and Koszytkowska-Stawin´ska, M. Synthesis and antiviral evaluation of acyclic azanucleosides developed from sulfanilamide as a lead structure. Bioorg. Med. Che; 2008.16:8379–8389.
• [20] Subhakara, N.R., Sarinivas R.A., Adharvana, M.C., Ravi, K.V., Jyothy, V and Himabindu, V. Synthesis and antimicrobial activity of sulfonamide derivatives at c-8 alkyl chain of anacardic acid mixture isolated from a natural product cashew nut shell liquid (CNSL). Journal of Chemical Science; 2012, 124: 723-730
• [21] Blonde, I. Sildenafil citrate for eractile dysfunction in man with diabetes and cardiovascular risk factor: A retrospective analysis of pooled data from placebo-controlled trials. Current Medicinal Research Opinio; 2006, 22(II). 2111-2120
• [22] Gonzalez M. A., Gorman D. B., Hamilton C. T., and Roth G. A. Process development for the sulfonamide herbicide pyroxsulam. Organic Process Research & Developmen;. 2008, 12(2): 301–303
• [23] Eno, E.E., Taer,A., Fatma, K., Ian, L.,Cemil, O., Murat, S and Saviour, A.U. Theoretical studies of some sulphonamides as common inhibitors for mild steel in acidic medium. Intanational Journal of Quantum Chemistry; 2010, 110, 2614-2636
• [24] Adindu, Chinonso, B., Dike Kelechi, S., Chidiebere, Maduabuchi, A., Ikpa Chinyere, B. C. and Okafor, Kevin, U. Investigating The Corrosion And Microbial Inhibiting Properties Of Some Sulphonamide Compounds. Gsj: 2021, 9 (7).
• [25] Brackett, C.C., Singh, H., and Block, J.H. Likelihood and mechanisms of cross-allergenicity between sulfonamide antibiotics and other drugs containing a sulphonamide functional group. Pharmacolotherapy 2004, 24(7):856-70
• [26] Byarugaba, D.K. A view on antimicrobial resistance in developing countries and responsible risk factors. Int J Antimicrob Agents; 2004, 24: 105–10
• [27] Laxminarayan R, Duse A, Wattal C, Zaidi AKM, Wertheim HFL, Sumpradit N, Antibiotic resistance-the need for global solutions. Lancet Infect Dis; 2013. 13: 1057–98
• [28] Mancuso, G. Midiri, A., Gerace, E.and Biondo, C. Bacterial Antibiotic Resistance: The Most Critical Pathogens. Pathogens; 2021, 10, 1310
• [29] Cornaglia, G. Fighting infections due to multidrug-resistant Gram-positive pathogens. Clinical Microbiology and Infection; 2009, 15(3): 209–211
• [30] Sliwoski, G., Kothiwale, S., Meiler, J., and Lowe, E.W. Computational methods in drug discovery. Pharmacol Rev; 2013, 66(1): 334-95
• [31] Steven, M. Ronkin, Michael, Badia, Steve, Bellon, Anne-Laure, Grillot, Christian, H. Gross, Trudy, H., Grossman, Nagraj Mani, Jonathan, D. Parsons., Dean, Stamos, Martin, Trudeau, Yunyi, Wei, and Paul, S. Charifson. Discovery of pyrazolthiazoles as novel and potent inhibitors of bacterial gyrase. Bioorganic & Medicinal Chemistry Letters; 2010, 20: 2828–2831
• [32] Osman, K.T., Du, L., He, Y., and Luo, Y. Crystal structure of Bacillus aureus D-alanyl carrier protein ligase (DltA) in complex with ATP. J. Mol. Biol; 2009, 388: 345-355
• [33] Liang, X., Lee, C.J., Chen, X., Chung, H.S., Zeng, D., Raetz, C.R., Li, Y., Zhou, P., and Toone, E.J. Syntheses, structures and antibiotic activities of LpxC inhibitors based on the diacetylene scaffold. Bioorg Med Chem; 2011, 15; 19(2): 852-60
• [34] Ikpa, Chinyere B.C And Okoro, Uchechukwu C. Synthesis of New Para-toluene Sulphonamide Derivatives of Amino Acids and Their Anti Bacterial Activities. IOSR Journal of Applied Chemistry (2016, 9 (6)
• [35] Olayinka, O. Ajani, Oluwole, B. Familoni, Johnbull, O. Echeme, Feipeng, Wu, and Zheng, Sujiang. Synthesis and Antibacterial Activity of N,N-Diethylamide Bearing Benzenesulfonamide Derivatives. American Chemical Science Journal 2013, 3(1): 34-49
• [36] Ikpa, Chinyere B.C., Okoro Uchechukwu C., Ubochi Collins I and Nwanorh Kieran O. Synthesis, Characterization and Antibacterial Activity of 2-Phenylsulphonamide Derivatives of Some Amino Acids. International Letters of Chemistry, Physics and Astronomy 2016, 3, (70): 42-47
• [37] Ratchanok, P., Prasit, M., Veda, P., Anusit, T., Supaluk, P., Somsak, R., and Virapong, P. Investigations on Anticancer and Antimalarial Activities of Indole-Sulfonamide Derivatives and In Silico Studies. ACS Omega 2021, 6, 47, 31854–31868
• [38] Ugwu, D.I., Okoro, U.C., Ukoha, P.O., Gupta, A. and Okafor.S.N. Novel anti-inflammatory and analgesic agents: synthesis, molecular docking and in vivo studies, Journal of Enzyme Inhibition and Medicinal Chemistry; 2018, 33: 1, 405-415
• [39] McNally, V.A., Rajabi. M., Gbaj, A. Design, synthesis and enzymatic evaluation of 6-bridged imidazolyluracil derivatives as inhibitors of human thymidine phosphorylase. J Pharm Pharmacol 2007, 59: 537-542
• [40] Alumi, Z., Belaidi, S., Lanez, T., and Tchouar, N. Structure activity relationship, QSAR modeling and drug-like calculations of TP inhibition of 1,3,4-oxadiazoline-2-thione derivatives. Int Lett Chem Phys Astron 2014, 37: 113–24
• [41] Veber, D.F., Johnson, S.R., Cheng, H.Y., Smith, B.R., Ward, K.W., and Kopple, K.D Molecular Properties That Influence the Oral Bioavailability of Drug Candidates. J. Med. Chem 2002, 45, 2615–2623

• Typ dokumentu: article